Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 150

Sort by

Sort Order Select

Journal Articles

Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatment

Blood (2025) 146 (Supplement 2): LBA-2.

https://doi.org/10.1182/blood-2025-LBA-2

Published: 2025

Journal Articles

The single-cell transcriptomic dissection analysis: Platelet-t cell/macrophage crosstalk and immune imbalance in aplastic anemia (AA)

Shuai Tan, Fang Fang, Jing Sun, Yumeng Li, Yaochi Chen, Wanling Sun

Blood (2025) 146 (Supplement 1): 6723.

https://doi.org/10.1182/blood-2025-6723

Published: 2025

Journal Articles

Initiating Eltrombopag (EPAG) Early for aplastic Anemia (AA) may Lead to greater clinical benefits: A systematic review and meta-analysis

Shuai Tan, Mingyue Shang, Yixian Guo, Li Su, Huanyuan Wang, Qiang Ma, Wuhan Hui, Jing Ni, Zehao Cai, Huizhen He, Yaofang Cao, Yuxin Li, Yumeng Li, Yaochi Chen, Jing Sun, Wanling Sun

Blood (2025) 146 (Supplement 1): 6721.

https://doi.org/10.1182/blood-2025-6721

Published: 2025

Journal Articles

Phase 3 ESLIM-01 study: Final analysis of efficacy and safety of long-term treatment with sovleplenib in adults with chronic primary immune thrombocytopenia

Blood (2025) 146 (Supplement 1): 843.

https://doi.org/10.1182/blood-2025-843

Published: 2025

Journal Articles

Sorafenib enhances anti-leukemia effect via promoting macrophage-NK cell immune crosstalk in FLT3-ITD+ AML patients receiving allo-HSCT

Ruoyang Shao, Peiru Chi, Yuxin Bai, Fang Dai, Tian Zhang, Zhonghui Jiang, Xi Xu, Xiaofeng Yang, Kejing Li, Guo Qiu, Yueyang Zhong, Na Xu, Fen Huang, Zhiping Fan, Ren Lin, Hua Jin, Jing Sun, Qifa Liu, Xuan Li

Blood (2025) 146 (Supplement 1): 2308.

https://doi.org/10.1182/blood-2025-2308

Published: 2025

Journal Articles

High treatment compliance and tolerability with fitusiran antithrombin-based dose regimen in people with hemophilia A or B, with or without inhibitors: ATLAS-OLE study

Mindy Simpson, Chia-Yau Chang, Kaan Kavakli, Steven Pipe, Jing Sun, Chur-Woo You, Lila-Sabrina Fetita, Abhimanyu Yarramaneni, Chuanwu Zhang, Sandra Casiano, Arta Subagiarta, Erin Cockrell

Blood (2025) 146 (Supplement 1): 1298.

https://doi.org/10.1182/blood-2025-1298

Published: 2025

Journal Articles

Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study

Guy Young, Kaan Kavakli, Robert Klamroth, Tadashi Matsushita, Flora Peyvandi, Steven W. Pipe, Savita Rangarajan, Ming-Ching Shen, Alok Srivastava, Jing Sun, Huyen Tran, Chur-Woo You, Bülent Zülfikar, Laurel A. Menapace, Chuanwu Zhang, Yuqian Shen, Marja Puurunen, Marek Demissie, Gili Kenet

Blood (2025) 145 (25): 2966–2977.

https://doi.org/10.1182/blood.2024027008

Published: 2025

Includes: Supplemental data

Journal Articles

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 7385.

https://doi.org/10.1182/blood-2024-203334

Published: 2024

Journal Articles

Demographics and Clinical Profile of Hemophilia Patients in China - Results from a Cross-Sectional, Community-Based Survey

Feng Xue, Chun Chang, Karina Chin Po Hsu, Jing Sun, Xinsheng Zhang, Shujie Wang, Jingsheng Wu, Rong Chen, Danni Shi, Felix Cao, Renchi Yang

Blood (2024) 144 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2024-207783

Published: 2024

Journal Articles

Pharmacokinetics and Pharmacodynamics of Novel Long-Acting Pegylated Recombinant Asparaginase Comparing with Pegaspargase: A Dose-Escalation, Phase Ia Trial in Chinese Healthy Subjects

Kai Fan, Qing Chen, Yunfeng He, Guanghui Tang, Liexing Xu, Jing Sun

Blood (2024) 144 (Supplement 1): 5905.

https://doi.org/10.1182/blood-2024-201156

Published: 2024

Journal Articles

Efficacy and Safety of an Engineered, Liver-Tropic Adeno-Associated Virus Vector Expressing Factor IX Padua Administered with Prophylactic Glucocorticoids in Patients with Hemophilia B: A Multi-Center, Single-Arm, Phase 3 Trial

Feng Xue, Mankai Ju, Tienan Zhu, ZePing Zhou, Jing Sun, Linhua Yang, Zhenyu Yan, Hu Zhou, Xin Du, Changcheng Zheng, Xia Wu, Xiao Xiao, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 3582.

https://doi.org/10.1182/blood-2024-204715

Published: 2024

Journal Articles

Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study

Hu Yingying, Xuan Zhou, Shuhua Li, Jing Sun, Jieyu Ye, Qifa Liu, Houmei Feng

Blood (2024) 144 (Supplement 1): 3979.

https://doi.org/10.1182/blood-2024-206976

Published: 2024

Journal Articles

Long-Term Sovleplenib Treatment of Adults with Primary Immune Thrombocytopenia in China

Blood (2024) 144 (Supplement 1): 2558.

https://doi.org/10.1182/blood-2024-204447

Published: 2024

Journal Articles

Efficacy and Safety of Pegylated Peptide Agonist of Thrombopoietin Receptor (PN20) in Secondary Prevention of Chemotherapy-Induced Thrombocytopenias: A Multicenter, Single Arm, Phase Ib Trial

Kai Fan, Qing Chen, Shehui Hu, Xin Zeng, Xiaolan Qin, Jing Sun

Blood (2024) 144 (Supplement 1): 1190.

https://doi.org/10.1182/blood-2024-202698

Published: 2024

Journal Articles

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Yifei Huang, Ren Lin, Shanyu Zhang, Zhiping Fan, Fen Huang, Li Xuan, Na Xu, Hui Liu, Zhixiang Wang, Min Dai, Hua Jin, Jing Sun, Qifa Liu

Blood (2024) 144 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2024-202355

Published: 2024

Journal Articles

Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Zhonghui Jiang, Zhiping Fan, Hui Xu, Na Xu, Tian Zhang, Huiwen Xue, Ren Lin, Zhixiang Wang, Ling Jiang, Jing Sun, Li Xuan

Blood (2023) 142 (Supplement 1): 4871.

https://doi.org/10.1182/blood-2023-178337

Published: 2023

Journal Articles

Granulocyte Colony-Stimulating Factor and Decitabine-Containing Conditioning Improves Survival in Myelodysplastic Syndrome Patients with Iron Overload Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Wenshu Zhao, Danqi Pan, Xiangzong Zeng, Li Xuan, Zhiping Fan, Fen Huang, Na Xu, Jing Sun, Qifa Liu, Min Dai

Blood (2023) 142 (Supplement 1): 3538.

https://doi.org/10.1182/blood-2023-184481

Published: 2023

Journal Articles

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Fen Huang, Jing Du, Pinjing Lv, Kaibo Yang, Zhiping Fan, Li Xuan, Jing Sun, Na Xu, Hui Liu, Pengcheng Shi, Xiaofang LI, Jun Xu, Zhixiang Wang, Pu Wang, Xiang Yao, Ye Chen, Qifa Liu

Blood (2023) 142 (Supplement 1): 3569.

https://doi.org/10.1182/blood-2023-179098

Published: 2023

Journal Articles

Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement

Bailin He, Hongsheng Zhou, Ren Lin, Zhixiang Wang, Na Xu, Qiang Wang, Jing Sun, Xiaoli Liu, Peng Li, Qifa Liu

Blood (2023) 142 (Supplement 1): 3484.

https://doi.org/10.1182/blood-2023-184492

Published: 2023

Journal Articles

BinaryClust2: An Integrated Computational Pipeline for Systematic Mining of Mass Cytometry Data to Assist Deep Immune Profiling in Haematological Research

Jing Sun, Desmond Choy, Nicolas Sompairac, Shirin Jamshidi, Michele Mishto, Shahram Kordasti

Blood (2023) 142 (Supplement 1): 124.

https://doi.org/10.1182/blood-2023-177676

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Primary results from VAYHIT2, a randomized, double-blind, phase 3 trial of ianalumab plus eltrombopag versus placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatment

The single-cell transcriptomic dissection analysis: Platelet-t cell/macrophage crosstalk and immune imbalance in aplastic anemia (AA)

Initiating Eltrombopag (EPAG) Early for aplastic Anemia (AA) may Lead to greater clinical benefits: A systematic review and meta-analysis

Phase 3 ESLIM-01 study: Final analysis of efficacy and safety of long-term treatment with sovleplenib in adults with chronic primary immune thrombocytopenia

Sorafenib enhances anti-leukemia effect via promoting macrophage-NK cell immune crosstalk in FLT3-ITD+ AML patients receiving allo-HSCT

High treatment compliance and tolerability with fitusiran antithrombin-based dose regimen in people with hemophilia A or B, with or without inhibitors: ATLAS-OLE study

Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Demographics and Clinical Profile of Hemophilia Patients in China - Results from a Cross-Sectional, Community-Based Survey

Pharmacokinetics and Pharmacodynamics of Novel Long-Acting Pegylated Recombinant Asparaginase Comparing with Pegaspargase: A Dose-Escalation, Phase Ia Trial in Chinese Healthy Subjects

Efficacy and Safety of an Engineered, Liver-Tropic Adeno-Associated Virus Vector Expressing Factor IX Padua Administered with Prophylactic Glucocorticoids in Patients with Hemophilia B: A Multi-Center, Single-Arm, Phase 3 Trial

Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study

Long-Term Sovleplenib Treatment of Adults with Primary Immune Thrombocytopenia in China

Efficacy and Safety of Pegylated Peptide Agonist of Thrombopoietin Receptor (PN20) in Secondary Prevention of Chemotherapy-Induced Thrombocytopenias: A Multicenter, Single Arm, Phase Ib Trial

Increased EBV Infection and Relapse Rates Following Haploidentical Hematopoietic Cell Transplantation in the Era of Letermovir for Cytomegalovirus Prophylaxis: A Propensity Score Matching Analysis

Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Granulocyte Colony-Stimulating Factor and Decitabine-Containing Conditioning Improves Survival in Myelodysplastic Syndrome Patients with Iron Overload Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement

BinaryClust2: An Integrated Computational Pipeline for Systematic Mining of Mass Cytometry Data to Assist Deep Immune Profiling in Haematological Research

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only